BetaGlue Therapeutics SpA
BetaGlue Therapeutics SpA
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC | Locally Advanced; Pancreatic Ductal Adenocarcinoma (PDAC); Unresectable | Recruiting | Not applicable | 2026-02-19 | NCT07155850 |